A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers
NCT01023100 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2010-06-16
Summary
This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.
Conditions
- Arthritis, Rheumatoid
Interventions
- DRUG
-
CP 690,550 oral solutions
flavored and unflavored prototype CP-690,550 formulations
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants
NCT04839809 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect Study of CTP-543 in Healthy Volunteers
NCT03880136 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Celecoxib Bioavailability in Healthy Subjects
NCT00296127 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects
NCT01184001 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Relative Bioavailability of a Pediatric Granule Formulation of Ozanimod in Healthy Adult Subjects
NCT04528290 ·Status: COMPLETED ·Phase: PHASE1
-
3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule
NCT02034773 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects
NCT03135509 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.
NCT06003829 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501
NCT01549054 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
NCT01866007 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men
NCT02236988 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation
NCT05263895 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
NCT05467696 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects
NCT01905553 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers
NCT02690727 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Of Celecoxib Test Formulations
NCT00925106 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants
NCT05099822 ·Status: TERMINATED ·Phase: PHASE1
-
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects
NCT01053520 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects
NCT01260155 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of K0706 in Healthy Subjects
NCT03316820 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults
NCT02666963 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule
NCT01297595 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532
NCT01388829 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body
NCT05515588 ·Status: COMPLETED ·Phase: PHASE1